A Systematic Review of Economic Evaluations of Pharmacogenetic Testing for Prevention of Adverse Drug Reactions

Background Pharmacogenetics offers the potential to improve health outcomes by identifying individuals who are at greater risk of harm from certain medicines. Routine adoption of pharmacogenetic tests requires evidence of their cost effectiveness. Objective The present review aims to systematically...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	PharmacoEconomics Jg. 34; H. 8; S. 771 - 793
Hauptverfasser:	Plumpton, Catrin O., Roberts, Daniel, Pirmohamed, Munir, Hughes, Dyfrig A.
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	Cham Springer International Publishing 01.08.2016 Springer Springer Nature B.V
Schlagworte:	Adverse and side effects Cost-Benefit Analysis Drug-Related Side Effects and Adverse Reactions - economics Drug-Related Side Effects and Adverse Reactions - epidemiology Drug-Related Side Effects and Adverse Reactions - prevention & control Drugs Economic aspects Evaluation Genotype Health Administration Health Economics Humans Incidence Medicine Medicine & Public Health Methods Pharmacoeconomics and Health Outcomes Pharmacogenetics Pharmacogenetics - economics Pharmacogenetics - methods Pharmacogenomic Testing - economics Pharmacogenomic Testing - methods Public Health Quality of Life Research Side effects Systematic Review United Kingdom Prasugrel Clopidogrel Economic Evaluation Carbamazepine Abacavir
ISSN:	1170-7690, 1179-2027
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!